Pharma Voice 100 of the Most Inspiring People



 
Esprit Pharma, Inc. to be aquired by Allergan, Inc.
more
Esprit Pharma Secures Marketing Rights to SANCTURAŽ XR
more
Esprit Pharma Elects Robert E. Baldini to Its Board of Directors
more
Esprit Pharma Successfully Completes a Series B Financing, Raising in Excess of $90 Million
more
Media Center
Email ESPRIT Code of Conduct Terms of Use  


General Information: 732-828-9950 ·
Medical Affairs: 866-230-0375 x 1198 or medical.questions@espritpharma.com
This Site is Under Construction so Visit Often for Updates
© 2007 Esprit Pharma, Inc. All rights reserved
2 Tower Center Boulevard
East Brunswick, New Jersey 08816, USA
Use of this Web site is governed by our Terms of Use.